TY - JOUR AU - Minna, J. D. AU - Gazdar, A. F. AU - Sprang, S. R. PY - 2004 DA - 2004// TI - A bull’s eye for targeted lung cancer therapy JO - Science VL - 304 UR - https://doi.org/10.1126/science.1099578 DO - 10.1126/science.1099578 ID - Minna2004 ER - TY - JOUR AU - Fan, H. AU - Shao, Z. Y. AU - Xiao, Y. Y. PY - 2015 DA - 2015// TI - Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2015-009419 DO - 10.1136/bmjopen-2015-009419 ID - Fan2015 ER - TY - STD TI - Lastwika KJ, Wilson W 3rd, Li QK, et al. Control of PD-L1 expression by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer. Cancer Res. 2015. Epub ahead of print. ID - ref3 ER - TY - JOUR AU - Gasparini, P. AU - Cascione, L. AU - Landi, L. PY - 2015 DA - 2015// TI - microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1520329112 DO - 10.1073/pnas.1520329112 ID - Gasparini2015 ER - TY - JOUR AU - Sequist, L. V. AU - Waltman, B. A. AU - Dias-Santagata, D. PY - 2011 DA - 2011// TI - Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002003 DO - 10.1126/scitranslmed.3002003 ID - Sequist2011 ER - TY - JOUR AU - Kerbel, R. S. PY - 2005 DA - 2005// TI - Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed JO - Cancer Cell VL - 8 UR - https://doi.org/10.1016/j.ccr.2005.09.016 DO - 10.1016/j.ccr.2005.09.016 ID - Kerbel2005 ER - TY - JOUR AU - Carmeliet, P. AU - Jain, R. K. PY - 2011 DA - 2011// TI - Molecular mechanisms and clinical applications of angiogenesis JO - Nature VL - 473 UR - https://doi.org/10.1038/nature10144 DO - 10.1038/nature10144 ID - Carmeliet2011 ER - TY - JOUR AU - Xuan, Z. X. AU - Li, L. N. AU - Zhang, Q. PY - 2014 DA - 2014// TI - Fully human anti-VEGFR2 monoclonal antibody reduces tumor angiogenesis and inhibits tumor growth JO - Int J Oncol VL - 45 ID - Xuan2014 ER - TY - JOUR AU - Gerald, D. AU - Chintharlapalli, S. AU - Augustin, H. G. PY - 2013 DA - 2013// TI - Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-4697 DO - 10.1158/0008-5472.CAN-12-4697 ID - Gerald2013 ER - TY - JOUR AU - Felcht, M. AU - Luck, R. AU - Schering, A. PY - 2012 DA - 2012// TI - Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI58832 DO - 10.1172/JCI58832 ID - Felcht2012 ER - TY - JOUR AU - Danza, K. AU - Pilato, B. AU - Lacalamita, R. PY - 2013 DA - 2013// TI - Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer JO - Eur J Hum Genet VL - 21 UR - https://doi.org/10.1038/ejhg.2012.273 DO - 10.1038/ejhg.2012.273 ID - Danza2013 ER - TY - JOUR AU - Nasarre, P. AU - Thomas, M. AU - Kruse, K. PY - 2009 DA - 2009// TI - Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3030 DO - 10.1158/0008-5472.CAN-08-3030 ID - Nasarre2009 ER - TY - JOUR AU - Gu, Y. AU - Körbel, C. AU - Scheuer, C. PY - 2015 DA - 2015// TI - Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model JO - Oncotarget ID - Gu2015 ER - TY - JOUR AU - Monk, B. J. AU - Poveda, A. AU - Vergote, I. PY - 2014 DA - 2014// TI - Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double- blind, placebo-controlled phase 3 trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70244-X DO - 10.1016/S1470-2045(14)70244-X ID - Monk2014 ER - TY - JOUR AU - Gourley, C. PY - 2014 DA - 2014// TI - Trebananib: an alternative anti-angiogenic strategy JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70283-9 DO - 10.1016/S1470-2045(14)70283-9 ID - Gourley2014 ER - TY - JOUR AU - Maffei, R. AU - Martinelli, S. AU - Santachiara, R. PY - 2010 DA - 2010// TI - Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2009-11-252494 DO - 10.1182/blood-2009-11-252494 ID - Maffei2010 ER - TY - JOUR AU - Bupathi, M. AU - Kaseb, A. AU - Janku, F. PY - 2014 DA - 2014// TI - Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives JO - Onco Targets Ther VL - 7 ID - Bupathi2014 ER - TY - JOUR AU - Volkova, E. AU - Willis, J. A. AU - Wells, J. E. PY - 2011 DA - 2011// TI - Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer JO - Br J Cancer VL - 104 UR - https://doi.org/10.1038/sj.bjc.6606005 DO - 10.1038/sj.bjc.6606005 ID - Volkova2011 ER - TY - JOUR AU - Helfrich, I. AU - Edler, L. AU - Sucker, A. PY - 2009 DA - 2009// TI - Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1615 DO - 10.1158/1078-0432.CCR-08-1615 ID - Helfrich2009 ER - TY - JOUR AU - Coelho, A. L. AU - Araújo, A. AU - Gomes, M. PY - 2014 DA - 2014// TI - Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0090009 DO - 10.1371/journal.pone.0090009 ID - Coelho2014 ER - TY - JOUR AU - Fawzy, A. AU - Gaafar, R. AU - Kasem, F. PY - 2012 DA - 2012// TI - Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer JO - J Egypt Natl Canc Inst VL - 24 UR - https://doi.org/10.1016/j.jnci.2011.12.006 DO - 10.1016/j.jnci.2011.12.006 ID - Fawzy2012 ER - TY - JOUR AU - Andersen, S. AU - Donnem, T. AU - Al-Shibli, K. PY - 2011 DA - 2011// TI - Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2 JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0019773 DO - 10.1371/journal.pone.0019773 ID - Andersen2011 ER - TY - JOUR AU - Shijubo, N. AU - Kojima, H. AU - Nagata, M. PY - 2003 DA - 2003// TI - Tumor angiogenesis of non-small cell lung cancer JO - Microsc Res Tech VL - 60 UR - https://doi.org/10.1002/jemt.10257 DO - 10.1002/jemt.10257 ID - Shijubo2003 ER - TY - JOUR AU - Hall, R. D. AU - Le, T. M. AU - Haggstrom, D. E. PY - 2015 DA - 2015// TI - Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC) JO - Transl Lung Cancer Res VL - 4 ID - Hall2015 ER - TY - JOUR AU - Akın Kabalak, P. AU - Çiledağ, A. AU - Demir, N. PY - 2015 DA - 2015// TI - Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in patients with lung cancer JO - Tuberk Toraks VL - 63 UR - https://doi.org/10.5578/tt.9015 DO - 10.5578/tt.9015 ID - Akın Kabalak2015 ER - TY - JOUR AU - Reinmuth, N. AU - Piegelbrock, E. AU - Raedel, M. PY - 2007 DA - 2007// TI - Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer JO - Lung Cancer VL - 55 UR - https://doi.org/10.1016/j.lungcan.2006.09.025 DO - 10.1016/j.lungcan.2006.09.025 ID - Reinmuth2007 ER - TY - JOUR AU - Daly, S. AU - Kubasiak, J. C. AU - Rinewalt, D. PY - 2014 DA - 2014// TI - Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma JO - Ann Thorac Surg VL - 98 UR - https://doi.org/10.1016/j.athoracsur.2014.06.071 DO - 10.1016/j.athoracsur.2014.06.071 ID - Daly2014 ER - TY - JOUR AU - Huang, T. AU - Lu, C. AU - Lei, Z. PY - 2012 DA - 2012// TI - Expression of Ang-2, HIF-2α and VEGF in non-small cell lung carcinoma and its clinical significance JO - Chin J Clin VL - 6 ID - Huang2012 ER - TY - STD TI - Jiang AY, Yu RZ, Luo HL, et al. Expression of Tie2 and Ang2 in non-small cell lung cancer and its clinical significance. Evaluation and analysis of drug-use in hospitals of China. 2015;15(5):571–3. (published in Chinese). ID - ref29 ER - TY - JOUR AU - Li, M. Q. AU - Shi, X. K. AU - Long, Q. PY - 2015 DA - 2015// TI - Clinical significance of tumor Ang-2 for lung cancer detection JO - Heilongjiang Med J VL - 28 ID - Li2015 ER - TY - STD TI - Liu HY. The expression of Ang-2, CD105 and CD34 in NSCLC and their prognostic significance. Shandong University Master’s Thesis. 2010. (published in Chinese). ID - ref31 ER - TY - JOUR AU - Liu, Y. Y. AU - Wang, S. W. PY - 2014 DA - 2014// TI - Expressions and significance of VEGF and Ang-2 in serum of patients with NSCLC JO - Mod Oncol VL - 23 ID - Liu2014 ER - TY - JOUR AU - Massabeau, C. AU - Rouquette, I. AU - Lauwers-Cances, V. PY - 2009 DA - 2009// TI - Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer JO - Int J Radiat Oncol Biol Phys VL - 75 UR - https://doi.org/10.1016/j.ijrobp.2008.11.050 DO - 10.1016/j.ijrobp.2008.11.050 ID - Massabeau2009 ER - TY - JOUR AU - Park, J. H. AU - Park, K. J. AU - Kim, Y. S. PY - 2007 DA - 2007// TI - Serum angiopoietin-2 as a clinical marker for lung cancer JO - Chest VL - 132 UR - https://doi.org/10.1378/chest.06-2915 DO - 10.1378/chest.06-2915 ID - Park2007 ER - TY - JOUR AU - Park, J. H. AU - Choi, H. AU - Kim, Y. B. PY - 2009 DA - 2009// TI - Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer JO - Lung Cancer VL - 66 UR - https://doi.org/10.1016/j.lungcan.2009.03.002 DO - 10.1016/j.lungcan.2009.03.002 ID - Park2009 ER - TY - JOUR AU - Sasaki, H. AU - Suzuki, A. AU - Shitara, M. PY - 2012 DA - 2012// TI - Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer JO - Oncol Lett VL - 4 ID - Sasaki2012 ER - TY - JOUR AU - Takanami, I. PY - 2004 DA - 2004// TI - Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis JO - Oncol Rep VL - 12 ID - Takanami2004 ER - TY - JOUR AU - Tanaka, F. AU - Ishikawa, S. AU - Yanagihara, K. PY - 2002 DA - 2002// TI - Expression of angiopoietins and its clinical significance in non-small cell lung cancer JO - Cancer Res VL - 62 ID - Tanaka2002 ER - TY - JOUR AU - Wan, R. G. AU - Chen, D. B. AU - Zhou, S. H. PY - 2008 DA - 2008// TI - Clinical significance of serum angiopoietin-2 levels in non-small cell lung cancer JO - Zhejiang J Lab Med VL - 6 ID - Wan2008 ER - TY - JOUR AU - Wang, L. AU - Geng, T. AU - Guo, X. PY - 2015 DA - 2015// TI - Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer JO - Mol Med Rep VL - 11 ID - Wang2015 ER - TY - JOUR AU - Xiao, H. M. AU - Wu, L. P. AU - Hao, J. L. PY - 2010 DA - 2010// TI - The expression and their correlations of survivin and angiogenin-2 in non-small cell lung cancer JO - Chin J Clin Ration Drug Use VL - 3 ID - Xiao2010 ER - TY - JOUR AU - Xing, L. H. AU - Zhang, Z. X. AU - Xu, Y. J. PY - 2003 DA - 2003// TI - The expression of angiogenin-2 gene in non-small cell lung cancer tissue and significance JO - Chin J Tuberc Respir Dis VL - 26 ID - Xing2003 ER - TY - STD TI - Yuan B. Effect of hypoxia-inducible factor-1α on angiopoietin-2 expression in non-small cell lung cancer. Huazhong University of Science and Technology Master’s Thesis. 2007. (published in Chinese). ID - ref43 ER - TY - JOUR AU - Zhang, X. B. AU - Xia, X. Z. PY - 2008 DA - 2008// TI - The expression of angiogenin-2 (Ang-2) in non-small cell lung cancer (NSCLC) and the relationship between tumor angiogenesis JO - China Practical Medicine VL - 3 ID - Zhang2008 ER - TY - JOUR AU - Gadgeel, S. M. PY - 2016 DA - 2016// TI - Personalized therapy of non-small cell lung cancer (NSCLC) JO - Adv Exp Med Biol VL - 890 UR - https://doi.org/10.1007/978-3-319-24932-2_11 DO - 10.1007/978-3-319-24932-2_11 ID - Gadgeel2016 ER - TY - JOUR AU - Gure, A. O. AU - Chua, R. AU - Williamson, B. PY - 2005 DA - 2005// TI - Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-1203 DO - 10.1158/1078-0432.CCR-05-1203 ID - Gure2005 ER - TY - JOUR AU - Mazzieri, R. AU - Pucci, F. AU - Moi, D. PY - 2011 DA - 2011// TI - Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2011.02.005 DO - 10.1016/j.ccr.2011.02.005 ID - Mazzieri2011 ER - TY - JOUR AU - Thurston, G. AU - Daly, C. PY - 2012 DA - 2012// TI - The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway JO - Cold Spring Harb Perspect Med VL - 2 UR - https://doi.org/10.1101/cshperspect.a006650 DO - 10.1101/cshperspect.a006650 ID - Thurston2012 ER - TY - JOUR AU - Eroglu, Z. AU - Stein, C. A. AU - Pal, S. K. PY - 2013 DA - 2013// TI - Targeting angiopoietin-2 signaling in cancer therapy JO - Expert Opin Investig Drugs VL - 22 UR - https://doi.org/10.1517/13543784.2013.793306 DO - 10.1517/13543784.2013.793306 ID - Eroglu2013 ER -